迈博药业有限公司于2026年2月3日提交的月报显示，本次报告期为2026年1月，期内公司股本结构及发行情况保持稳定。公告称，公司注册股本为50,000,000,000股，面值为每股0.0001美元，总额维持在5,000,000美元。截至1月31日，普通股已发行股数为4,124,080,000股，与上一个月份持平，库藏股数量为零。
报告并披露，公司购股权计划期末未行使的购股权数量为72,670,876份，且本月内无新增发行、行使及注销。公司确认截至本月底，其满足香港联交所所要求的最低公众持股量规定。
公司同时说明，本月无购回或注销股票活动，股本总数未发生变化。公告由公司秘书曾浩贤先生签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.